Sex as a predictor of response to cancer immunotherapy - Authors' reply
- PMID: 30102230
- DOI: 10.1016/S1470-2045(18)30535-7
Sex as a predictor of response to cancer immunotherapy - Authors' reply
Comment on
-
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16. Lancet Oncol. 2018. PMID: 29778737
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e374. doi: 10.1016/S1470-2045(18)30446-7. Lancet Oncol. 2018. PMID: 30102224 No abstract available.
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e375. doi: 10.1016/S1470-2045(18)30443-1. Lancet Oncol. 2018. PMID: 30102225 No abstract available.
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e376. doi: 10.1016/S1470-2045(18)30483-2. Lancet Oncol. 2018. PMID: 30102226 No abstract available.
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e377. doi: 10.1016/S1470-2045(18)30517-5. Lancet Oncol. 2018. PMID: 30102227 Free PMC article. No abstract available.
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e378. doi: 10.1016/S1470-2045(18)30531-X. Lancet Oncol. 2018. PMID: 30102228 No abstract available.
-
Sex as a predictor of response to cancer immunotherapy.Lancet Oncol. 2018 Aug;19(8):e379. doi: 10.1016/S1470-2045(18)30445-5. Lancet Oncol. 2018. PMID: 30102229 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources